BDBM72297 1-benzyl-3-[2,2-dichloro-1-(3-fluoro-4-methyl-phenyl)ethyl]-1-methyl-urea::1-benzyl-3-[2,2-dichloro-1-(3-fluoro-4-methylphenyl)ethyl]-1-methylurea::3-[2,2-bis(chloranyl)-1-(3-fluoranyl-4-methyl-phenyl)ethyl]-1-methyl-1-(phenylmethyl)urea::3-[2,2-dichloro-1-(3-fluoro-4-methylphenyl)ethyl]-1-methyl-1-(phenylmethyl)urea::MLS000374987::SMR000254341::cid_3262851

SMILES O=C1c2cc(C(F)(F)F)ncc2N2CN1c1ccc(=O)[nH]c1CCCCCc1cc(F)ccc12

InChI Key InChIKey=PNQIANRADZBYEG-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72297   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72297BDBM72297(34-Fluoro-26-(trifluoromethyl)-11,12,21,22,23,24-h...)
Affinity DataIC50: 25.1nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
US Patent